ArticleScientific reports2015

Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome.

Julie Plée et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.